Gregory Sullivan
2019
In 2019, Gregory Sullivan earned a total compensation of $652.4K as Chief Medical Officer at Tonix Pharmaceuticals Holding, a 10% decrease compared to previous year.
Compensation breakdown
| Bonus | $84,000 |
|---|---|
| Option Awards | $168,393 |
| Salary | $400,000 |
| Total | $652,393 |
Sullivan received $400K in salary, accounting for 61% of the total pay in 2019.
Sullivan also received $84K in bonus and $168.4K in option awards.
Rankings
In 2019, Gregory Sullivan's compensation ranked 10,953rd out of 13,971 executives tracked by ExecPay. In other words, Sullivan earned more than 21.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,953 out of 13,971 | 22nd |
Division Manufacturing | 4,427 out of 5,695 | 22nd |
Major group Chemicals And Allied Products | 1,731 out of 2,194 | 21st |
Industry group Drugs | 1,485 out of 1,880 | 21st |
Industry Pharmaceutical Preparations | 1,096 out of 1,392 | 21st |
Source: SEC filing on March 30, 2020.
Sullivan's colleagues
We found two more compensation records of executives who worked with Gregory Sullivan at Tonix Pharmaceuticals Holding in 2019.
News
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2023 pay falls 55% to $2.1M
April 15, 2024
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2022 pay falls 41% to $4.6M
March 17, 2023
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2021 pay jumps 99% to $7.7M
March 18, 2022
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2020 pay jumps 201% to $3.9M
March 31, 2021
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2019 pay slips 13% to $1.3M
March 30, 2020
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2018 pay jumps 157% to $1.5M
March 18, 2019